Nervonik
4 known investors
Nervonik develops peripheral nerve stimulation systems optimized for high-motion applications with novel biosensing technology. The company targets neuromodulation and medical device markets with improved lead stability, connectivity, and durability for long-term efficacy.
Investors · 4
In the news
- Nervonik closes $52.5m Series B funding to advance PNS systemfinance.yahoo.com · 2026
- Nervonik Raises $52.5M to Advance Smart Neuromodulation Implants | citybizcitybiz.co · 2026
- Nervonik Raises $52.5M in Series B Fundingfinsmes.com · 2026
- Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapyprnewswire.com · 2026
- Nervonik raises $13M Series A to support next-gen nerve stim techmassdevice.com · 2025
- Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Reliefprnewswire.com · 2025